About Windhoek Healthcare
Windhoek Healthcare LLC is a healthcare investment firm started by senior executives of the pharmaceutical industry. It is seeking to maximize investor returns while pursuing opportunities that improve human healthcare. Our current focus is in Specialty Pharmaceuticals and Biotechnology.
In December of 2011, Windhoek Healthcare launched its second company, Laurel Pharmaceuticals, Inc. to focus on novel delivery of existing medicines.
North Creek Pharmaceuticals launches dapsone tablets in the United States
Laurel Pharmaceutical's University partner successfully completes Phase 2 PoC trial for novel otitis media treatment
North Creek Pharmaceuticals receives FDA approval for dapsone tablets
North Creek Pharmaceuticals receives FDA approval for tranexamic acid for injection
Laurel Pharmaceutical's University partner commences Phase 2 PoC trial for novel Otitis Media treatment
North Creek Pharmaceuticals signs development and distribution agreement with Virtus Pharmaceuticals
North Creek Pharmaceuticals acquires the rights to a portfolio of products from a leading South Korean manufacturer
Laurel Pharmaceuticals files Patent application with USPTO on novel Otitis Media Treatment
Laurel Pharmaceuticals files two PCTs patent application for novel drug formulation
North Creek Pharmaceuticals signs a strategic commercialization and drug development partnership
Laurel Pharmaceuticals enters into strategic University agreement to develop novel products
Laurel Pharmaceuticals Commences operations
North Creek Pharmaceuticals submits its first ANDA
North Creek Pharmaceuticals commences operations
Windhoek Healthcare initiates first fund to launch start-up pharmaceutical business
© Windhoek Healthcare LLC. 2011. All Rights Reserved.